Valuation Haemonetics Corporation
Stocks
HAE
US4050241003
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.34 USD | -0.71% |
|
-0.79% | -7.35% |
| 06-29 | Haemonetics Corporation(NYSE:HAE) added to Russell 2000 Value Benchmark | CI |
| 06-28 | Haemonetics Corporation(NYSE:HAE) added to Russell 2000 Value-Defensive Index | CI |
Company Valuation: Haemonetics Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,068 | 3,992 | 4,335 | 3,175 | 2,511 | 3,403 | - | - |
| Change | - | 30.13% | 8.58% | -26.76% | -20.89% | 35.51% | - | - |
| Enterprise Value (EV) 1 | 3,582 | 4,473 | 4,335 | 4,093 | 3,490 | 4,075 | 3,788 | 3,480 |
| Change | - | 24.89% | -3.1% | -5.58% | -14.71% | 16.76% | -7.06% | -8.13% |
| P/E | 71.5x | 35.3x | 37.3x | 19.1x | 26.4x | 19x | 16.8x | 13.9x |
| PBR | 4.09x | 4.88x | - | 3.71x | 3.21x | 2.82x | 2.24x | 1.84x |
| PEG | - | 0x | 16.71x | 0.4x | -0.7x | 0.2x | 1.3x | 0.7x |
| Capitalization / Revenue | 3.09x | 3.42x | 3.31x | 2.33x | 1.88x | 2.43x | 2.31x | 2.19x |
| EV / Revenue | 3.61x | 3.83x | 3.31x | 3.01x | 2.62x | 2.91x | 2.57x | 2.24x |
| EV / EBITDA | 12.6x | 14.7x | 11.7x | 9.67x | 7.93x | 9.13x | 7.8x | - |
| EV / EBIT | 19.1x | 20.5x | 15.7x | 12.5x | 10.3x | 11.2x | 9.56x | 8.18x |
| EV / FCF | - | - | 37.5x | 33.7x | 13.4x | 14.2x | 13.4x | 11.5x |
| FCF Yield | - | - | 2.66% | 2.96% | 7.46% | 7.04% | 7.44% | 8.68% |
| Dividend per Share 2 | - | - | - | - | - | 2 | - | - |
| Rate of return | - | - | - | - | - | 2.67% | - | - |
| EPS 2 | 0.84 | 2.24 | 2.29 | 3.31 | 2.05 | 3.943 | 4.465 | 5.39 |
| Distribution rate | - | - | - | - | - | 50.7% | - | - |
| Net sales 1 | 993.2 | 1,169 | 1,309 | 1,361 | 1,334 | 1,400 | 1,474 | 1,553 |
| EBITDA 1 | 284.9 | 304.7 | 370.1 | 423.3 | 440.1 | 446.6 | 485.8 | - |
| EBIT 1 | 187.1 | 218.4 | 276.5 | 326.3 | 338.5 | 364.2 | 396 | 425.2 |
| Net income 1 | 43.38 | 115.4 | 117.6 | 167.7 | 97.31 | 173.2 | 203.1 | 242.7 |
| Net Debt 1 | 514.1 | 481.4 | - | 918 | 979.1 | 672.5 | 384.8 | 76.86 |
| Reference price 2 | 60.02 | 79.13 | 85.35 | 63.19 | 54.04 | 74.88 | 74.88 | 74.88 |
| Nbr of stocks (in thousands) | 51,112 | 50,448 | 50,786 | 50,237 | 46,471 | 45,446 | - | - |
| Announcement Date | 5/10/22 | 5/11/23 | 5/9/24 | 5/8/25 | 5/7/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 18.99x | 2.91x | 9.13x | 2.67% | 3.4B | |
| 23.7x | 3.55x | 13.32x | 2.66% | 167B | |
| 19x | 3.31x | 11.66x | 3.54% | 107B | |
| 16.74x | 0.19x | 11.96x | 0.78% | 59.24B | |
| 32.42x | 7.87x | 20.57x | 1.24% | 52.99B | |
| 38.95x | 3.07x | 10.55x | 2.46% | 43.07B | |
| 41.17x | 1.48x | 12.99x | 0.19% | 36.37B | |
| 30.06x | 5.36x | 17.08x | -.--% | 28.39B | |
| 42.29x | 7.33x | 26.44x | 0.25% | 25.16B | |
| 20.54x | 2.83x | 11.03x | 1.53% | 21.17B | |
| Average | 28.39x | 3.79x | 14.47x | 1.53% | 54.4B | |
| Weighted average by Cap. | 26.28x | 3.62x | 14.00x | 2.01% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- HAE Stock
- Valuation Haemonetics Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
